Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04163458 · ClinicalTrials.gov registry record · Phase 3
Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)
A Phase 3 study of Infertility, sponsored by Ferring Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 405
- Enrollment target
- 20
- Study locations
NCT04163458 is a Phase 3 study of Infertility that has completed, run by Ferring Pharmaceuticals. The registered enrollment target is 405 participants, below the 7,584-participant average among 74 other Infertility trials with a reported enrollment target (95% lower). The trial reports 20 study locations across 14 states.
The verdict
NCT04163458, a Phase 3 study of Infertility, has completed, sponsored by Ferring Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 405 participants
- Enrollment target
- 20
- Study locations
Study Summary
Development of multiple follicles and pregnancy in ovulatory women undergoing controlled ovarian stimulation as part of an assisted reproductive technology (ART) cycle.
Conditions Studied
Interventions
- DRUG MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL
- DRUG MENOPUR powder and solvent for solution for injection, 75 IU
- OTHER Placebo (for MENOPUR solution for injection in pre-filled pen)
- OTHER Placebo (for MENOPUR powder and solvent for solution for injection)
Study Locations (20)
Texas
- Center for Assisted Reproduction - Bedford
- Houston Fertility Institute - Houston
- Center of Reproductive Medicine - Webster
Connecticut
- Center for Advanced Reproductive Services PC - Farmington
- Yale Fertility Center - New Haven
Florida
- Fertility and IVF Center of Miami - Miami
- Center for Reproductive Medicine - Winter Park
Illinois
- Fertility Centers of Illinois - Chicago
- InVia Fertility Specialists, SC - Hoffman Estates
North Carolina
- Reproductive Endocrinology Associates of Charlotte - Charlotte
- Carolina Conceptions - Raleigh
Arizona
- Fertility Treatment Center - Tempe
California
- Fertility Specialists Medical Group - San Diego Center for Reproductive Surgery - San Diego
Idaho
- Idaho Center for Reproductive Medicine - Boise
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 405 participants |
| Start Date | 2019-10-25 |
| Est. Completion | 2021-07-16 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04163458
The ClinicalTrials.gov registry entry for NCT04163458 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 405 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,584-participant average among 74 other Infertility trials with a reported enrollment target (95% lower). The listed sponsor is Ferring Pharmaceuticals, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Infertility appearing as the primary indexed condition, and to 4 interventions - of which MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL is the first listed.
NCT04163458 reports 20 study locations spanning 14 distinct geographic areas - top geographies include Texas, Connecticut, Florida.
Frequently Asked Questions
What is clinical trial NCT04163458 about?
NCT04163458 is a clinical study titled "Comparison of MENOPUR Liquid and Powder in Women Undergoing Assisted Reproductive Technology (ART)". Development of multiple follicles and pregnancy in ovulatory women undergoing controlled ovarian stimulation as part of an assisted reproductive technology (ART) cycle.
What is the current status of trial NCT04163458?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 405 participants. The study started on 2019-10-25. Estimated completion is 2021-07-16.
What conditions does trial NCT04163458 study?
This clinical trial studies the following conditions: Infertility.
What interventions are being tested in trial NCT04163458?
The interventions under investigation include: MENOPUR solution for injection in pre-filled pen, 1200 IU/1.92 mL (DRUG), MENOPUR powder and solvent for solution for injection, 75 IU (DRUG), Placebo (for MENOPUR solution for injection in pre-filled pen) (OTHER), Placebo (for MENOPUR powder and solvent for solution for injection) (OTHER).
Who is sponsoring clinical trial NCT04163458?
This trial is sponsored by Ferring Pharmaceuticals, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04163458 being conducted?
This trial has 20 study locations across Arizona, California, Connecticut, Florida, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Infertility
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pre-IVF Treatment With a GnRH Antagonist in Women With endometriosis_temp
RECRUITING · Phase 3
-
Fertility Preservation Using Tamoxifen and Letrozole in Estrogen Sensitive Tumors Trial
RECRUITING · Phase 3
-
Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.
ACTIVE NOT RECRUITING · Phase 3
-
Vaginal Culture Using INVOcell Compared to Traditional IVF Incubation
COMPLETED · Phase 3
-
A Clinical Trial to Evaluate the Efficacy and Safety of DR-2011 for In Vitro Fertilization
COMPLETED · Phase 3
-
Gamete Treatment to Correct Fertilization Failure
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.